Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort

Journal of Urology

Volumn 182, Issue 6, 2009, Pages 2702-2707

  Wright, Jonathan L ^a,b   Salinas, Claudia A ^b   Lin, Daniel W ^a,b   Kolb, Suzanne ^b   Koopmeiners, Joseph ^b   Feng, Ziding ^b   Stanford, Janet L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

disease progression; mortality; outcome assessment (health care); prostate; prostatic neoplasms

Indexed keywords

ANTIANDROGEN;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 71849115132     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.026     Document Type: Article

References (19)

1. Albertsen P.C., Hanley J.A., and Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (2005) 2095
2. Bianco Jr. F.J., Wood Jr. D.P., Cher M.L., et al. Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer. Clin Prostate Cancer 1 (2003) 242
3. Cuzick J., Fisher G., Kattan M.W., et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 95 (2006) 1186
4. Chan T.Y., Partin A.W., Walsh P.C., et al. Prognostic significance of Gleason score 3 + 4 versus Gleason score 4 + 3 tumor at radical prostatectomy. Urology 56 (2000) 823
5. Herman C.M., Kattan M.W., Ohori M., et al. Primary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol 25 (2001) 657
6. Lau W.K., Blute M.L., Bostwick D.G., et al. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. J Urol 166 (2001) 1692
7. Rasiah K.K., Stricker P.D., Haynes A.M., et al. Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98 (2003) 2560
8. Collette L. Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials. Eur Urol 53 (2008) 6
9. Stephenson A.J., Kattan M.W., Eastham J.A., et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy. a proposal for a standardized definition. J Clin Oncol 24 (2006) 3973
10. Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433
11. D'Amico A.V., Moul J., Carroll P.R., et al. Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer. J Urol 173 (2005) 1572
12. Stanford J.L., Wicklund K.G., McKnight B., et al. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 881
13. Little R.J.A., and Rubin D.B. Statistical Analysis With Missing Data (1987), Wiley, New York
14. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965
15. Ries L.A.G., Melbert D., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2005. Bethesda: National Cancer Institute. http://seer.cancer.gov/csr/1975_2005/ based on November 2007 SEER data submission. Posted to SEER web site 2008
16. Zhou P., Chen M.H., McLeod D., et al. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 23 (2005) 6992
17. Johansson J.E., Andren O., Andersson S.O., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713
18. Collin S.M., Martin R.M., Metcalfe C., et al. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 9 (2008) 445
19. Sim H.G., Telesca D., Culp S.H., et al. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. J Urol 179 (2008) 1775